建議您使用以下瀏覽器觀看本網站，
以獲得最佳瀏覽效果。
Our team
Ken Cheng
Metagone Biotech Group Founder
- Dongguan Shun Cheng Computer Enteprise Corporation Director of Board
- Solytech Enteprise Corporation President
- Experiences in R&D and manufacturing departments of electronic components industry management for over 30 years
- Biotech investing over 10 years experience
Sean Chen Ph.D.
President/General Manager
- MS/Ph.D., Neuroscience, College of Medicine, Ohio State University, Columbus, USA
- Research Fellow, Whitehead Institute for Biomedical Research, MIT, Boston, USA
- Department Head, R&D, Genovate Biotechnology Co., Ltd. Taiwan
- Founder/Board Director/General Manager, Transwell Biotechnology Co., Ltd. Taiwan
- Experiences in Drug development for over 30 years
Da-Wen Lu, Professor, M.D., Ph.D.
Medical Director
- Director, General Ophthalmology Department, Tri-Service General Hospital
- Director, Department of Glaucoma, Tri-Service General Hospital
- Professor, Department of Ophthalmology, National Defense Medical Center
- Chairman, Taiwan association for relief of glaucoma and effective therapy
Cheng-Kuo, Cheng, Associate Professor, M.D.
Medical Director
- Director, Department of ophthalmology and Retina Center of Shin Kong Hospital
- Executive Director, Taiwan Retina Society
- Associate Professor, Department of Medicine, Fu Jen Catholic University
- Director, Department of Ophthalmology, Fu Jen Catholic University
- Adjunct Assistant Professor, Department of Medicine, National Taiwan University
Cheng-Wen Lin Ph.D.
Chief Scientific Officer
- Ph.D., Biomedical Engineering, Durham, NC, Duke University
- Postdoctoral Fellow, Durham, NC, Duke University Eye Center
- Director of Research (Executive level), Aerie Pharmaceuticals, Inc. (now Alcon)
- Chief Scientific Officer, Perfuse Therapeutics, Inc.
- Experiences in ocular drug research and development for over 15 years
- Discovered and developed two marketed products (Rhopressa® & Rocklatan®)
Akaphot Thongmee (Mark), M.D.
Chief Medical Officer
Dr. Mark Thongmee, M.D., MRCP (UK), is a translational research physician trained in Translational Medicine and Early Phase Development from Imperial College London. With over a decade of experience, he has contributed significantly to clinical trials in infectious diseases and oncology across Southeast Asia, including leading community-based trials for HIV and HCV. He has spearheaded numerous research trials and medical initiatives, notably as;
- Global Medical Affairs lead at GPCRO Contract Research Organisation, leading the clinical trial designed and medical monitor for oncology, ophthalmology, COVID-19 infection, and gene therapy.
- Country Medical Director at Amgen and Allergan, he bridged clinical research with strategic medical affairs, enhanced drug accessibility, and implemented health economic outcomes research (HEOR) to support reimbursement strategies.
Simon Huang
Executive Vice President
- NYIT M.B.A.
- Barits Securities Corporation Researcher
- Solytech Enteprise Corporation Independent President
- Taipei Biotech Association Supervisor
- Professional experiences in clinical trail over 6 years
- Professional experiences (including the experiences of the securities industry and the investment company) in financial industry and capital market for over 20 years.
Amy Chen
Chief Financial Officer & Office of General Affairs, Director
- Royal Roads University M.B.A. in Executive Management
- Wayi International Digital Entertainment Co.,Ltd. Manager
- Professional experiences in financial management and fund allocation for over 25 years.
Te Chung Yang
Product Evaluation and Market Research, Director
- National Defense Medical Center Master of Pharmacy Institute
- Tri-Service General Hospital, Department of Clinical Pharmacy, Chief Pharmacist
- Tri-Service General Hospital, Department of Clinical Pharmacy, Quality Control and Clinical Trial Pharmacist
- Tri-Service General Hospital, Department of Clinical Pharmacy, Head of Neihu Outpatient Pharmacy Bureau
- Experiences in Clinical Pharmacy over 30 years
